ACVR2B/Fc counteracts chemotherapy-induced loss of muscle and bone mass

Chemotherapy promotes the development of cachexia, a debilitating condition characterized by muscle and fat loss. ACVR2B/Fc, an inhibitor of the Activin Receptor 2B signaling, has been shown to preserve muscle mass and prolong survival in tumor hosts, and to increase bone mass in models of osteogene...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Barreto, Rafael, Kitase, Yukiko, Matsumoto, Tsutomu, Pin, Fabrizio, Colston, Kyra C., Couch, Katherine E., O’Connell, Thomas M., Couch, Marion E., Bonewald, Lynda F., Bonetto, Andrea
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5665981/
https://ncbi.nlm.nih.gov/pubmed/29089584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-15040-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados